|
Volumn 28, Issue 5, 2000, Pages 337-345
|
Prevention of congenital toxoplasmosis
a a a |
Author keywords
Congenital toxoplasmosis; Neonatal screening; Prenatal screening; Prevention
|
Indexed keywords
FOLINIC ACID;
MACROLIDE;
PHENYLALANINE;
PYRIMETHAMINE;
SPIRAMYCIN;
SULFADIAZINE;
THYROXINE;
CHORIORETINITIS;
CLINICAL FEATURE;
DIAGNOSTIC PROCEDURE;
DISEASE TRANSMISSION;
HEALTH EDUCATION;
HUMAN;
HYDROCEPHALUS;
MENTAL DEFICIENCY;
NEWBORN SCREENING;
PREGNANCY;
PRENATAL DIAGNOSIS;
PRIMARY PREVENTION;
PRIORITY JOURNAL;
REVIEW;
RISK FACTOR;
SCREENING TEST;
SECONDARY PREVENTION;
SEROLOGY;
TOXOPLASMA GONDII;
TOXOPLASMOSIS;
ANIMALS;
ANTIBODIES, PROTOZOAN;
ANTIPROTOZOAL AGENTS;
FEMALE;
HUMANS;
INFANT, NEWBORN;
MASS SCREENING;
NEONATAL SCREENING;
PREGNANCY;
PREGNANCY COMPLICATIONS, PARASITIC;
PRIMARY PREVENTION;
TOXOPLASMA;
TOXOPLASMOSIS, CONGENITAL;
|
EID: 0034426196
PISSN: 03005577
EISSN: None
Source Type: Journal
DOI: 10.1515/JPM.2000.043 Document Type: Review |
Times cited : (63)
|
References (44)
|